CLINICAL_TRIALS
trial_result
· 2022-02-14
Clinical Trial Update: SCI-110 for Alzheimer Disease and Agitation [Phase 2]
Summary
Phase 2 clinical trial update for SCI-110 in Alzheimer disease and agitation is in early stages with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Israeli Medical Center for Alzheimer's | Conditions: Alzheimer Disease | Phase 2 | Status: UNKNOWN